Commentary

Podcast

Improving Relationships and Diversifying the Site Selection Process

Author(s):

Andy Studna, Senior Editor

In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.

Liz Beatty, co-founder and chief strategy officer, Inato, discusses:

  • Site engagement
  • Community-based sites
  • The role of technology in improving site/sponsor relationships
  • How increased operational costs are impacting the industry
  • and more!

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!
Related Videos
Related Content
Rethinking Oncology Trials With a Statistical Methodology That Puts Patients First
August 1st 2025

Rethinking Oncology Trials With a Statistical Methodology That Puts Patients First

Rudradev Sengupta
New statistical frameworks such as net treatment benefit offer a multidimensional approach to evaluating efficacy, safety, and patient-centered outcomes in oncology trials.
ACT Brief Episode 1: Placebos, Politics, and the Ethics of Vaccine Trials
August 1st 2025

ACT Brief Episode 1: Placebos, Politics, and the Ethics of Vaccine Trials

Applied Clinical Trials Editorial Staff
In this pilot episode of the Applied Clinical Trials Brief, we examine the renewed push for placebo-controlled vaccine trials in the US, why experts warn it violates core ethical standards, and how these proposals could jeopardize both participant safety and future innovation.
© JHVEPhoto - © JHVEPhoto - stock.adobe.com
August 1st 2025

FDA’s Elsa AI Tool Raises Accuracy and Oversight Concerns

Chris Mazzolini Mike Hollan
Despite ambitions to streamline regulatory review, FDA’s Elsa platform has been prone to hallucinations, prompting internal scrutiny and questions about AI reliability and governance.
Unifying Industry to Better Understand GCP Guidance
August 1st 2025

Unifying Industry to Better Understand GCP Guidance

Andy Studna, Senior Editor
In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
The 50-Year Technology Drought in Clinical Trials: How AI Teammates Will Finally Bring Us Into the Modern Era
August 1st 2025

The 50-Year Technology Drought in Clinical Trials: How AI Teammates Will Finally Bring Us Into the Modern Era

Gaurav Bhatnagar
Why a fundamental reimagining of how clinical studies operate is still necessary to achieve a true paradigm shift—and shed the cycle of reliance on incremental gains.
Obsolete Trial Marketing Guidelines and Missing Processes Hurt Patient Enrollment
August 1st 2025

Obsolete Trial Marketing Guidelines and Missing Processes Hurt Patient Enrollment

Christine Senn, PhD, FACRP
Outdated regulations and inflexible sponsor processes are hampering clinical trial recruitment, but empowering sites with modern, compliant marketing tools could turn the tide.
© 2025 MJH Life Sciences

All rights reserved.